Safety Takeaway: While the evidence from controlled human trials suggests a manageable adverse event profile, the products full extent of long-term safety, especially regarding chronic and rare side effects, remains undetermined until the completion of ongoing large-scale clinical programs and subsequent regulatory review and approval
Our team will discuss your medical history, goals, and options during a consultation
These are extraordinary numbers by any historical standard
Please come and ask questions that interest you!Speakers: Angelique Chettiparamb (University of Reading), David Kaufmann (ETH Zrich), Dominic Stead (Aalto University), Katie McClymont (University of the West of England Bristol), Tuna Tasan-Kok (University of Amsterdam) SS_22 ISTANBUL PLANNING AGENCY A0-11 (YTU Davutpasa Campus) A0-11 YTU Davutpasa Campus Convener: Oktay Kargul T_10 THEORIES: In memorial to Ben Davy - Academic Debates - What makes them interesting and challenging A1-13 (YTU Davutpasa Campus) A1-13 YTU Davutpasa Campus Conveners: Franziska Sielker (TU Wien), Meike Levin-Keitel, Stefano Moroni (Polytechnic University of Milan), Tanja Winkler (University of Cape Town), Prof